—

Medpace Holdings Inc (MEDP) — the peer cohort

As of 2026-10-06 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Medpace Holdings Inc ranks 3 of 6 in its cohort on the Closelooknet composite (63/100) — the cohort is led by DexCom Inc at 65/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
MEDP Medpace Holdings Inc 63 79 76 30 ok 11.1%
NTRA Natera Inc 44 92 23 6 bull 0.4%
DXCM DexCom Inc 65 78 81 37 bull 6.1%
ONC BeiGene, Ltd. 64 78 66 32 ok 5.8%
REGN Regeneron Pharmaceuticals Inc 60 56 72 51 watch 15.5%
CAI Caris Life Sciences, Inc. Common Stock 59 80 63 26 ok 18.4%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-06

Quick answers

Who are Medpace Holdings Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Natera Inc (NTRA), DexCom Inc (DXCM), BeiGene, Ltd. (ONC), Regeneron Pharmaceuticals Inc (REGN), Caris Life Sciences, Inc. Common Stock (CAI).

How does MEDP score against its peers?

Medpace Holdings Inc's composite reads 63/100, ranking 3 of 6 in its cohort as of 2026-10-06; the cohort's highest composite is DexCom Inc at 65/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.